Haunted by Tariffs and Trade Wars Peterson Institute Outlines Positive Trade Policy Path for US Agriculture Should You Sell GPAct III GPATW After 188 Drop 20260518 Zeo Energy ZEO Jumps 147 on Strong Momentum 20260518 SharonAI Holdings SHAZ Q1 2026 Results Fall Short EPS 143 Revenue NA US Consumer Sentiment Remains Subdued Amid Inflation Geopolitical Conflicts and Trade Policy Uncertainty FLEX LNG FLNG Gains 080 Support Holds at 3118 20260520 Paycom Software PAYC Posts Q1 2026 Earnings Beat Heres What Drove It Marc Jacobs Leaves LVMH Portfolio After Three Decades Remains Creative Director Prediction Market Investments Surge Despite Regulatory Uncertainty Tax Season 2026 New Rules for Online Sellers and EV Buyers Could Affect Your Refund Vestas Wind Systems Shares Tumble After Margin Warning Oil Prices Decline on Rising Hopes of USIran Nuclear Agreement BP Removes Chair Albert Manifold Amid Governance Concerns Appoints Ian Tyler as Interim Leader SP 500 Edges Higher as Healthcare and Technology Lead Communication Services Lags TCMD Q1 2026 Earnings NarrowerthanExpected Loss Fails to Lift Shares ES Q1 2026 Earnings EPS Misses Estimates Modest Stock Reaction IMMR Q3 2025 Earnings Strong EPS Beat Driven by Licensing and Royalty Revenue KRRO Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction NJR Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Regulatory Execution SK Hynix Reports Record Profit Amid AIDriven Memory Demand TSCO Q1 2026 Earnings EPS Miss Sends Stock Lower Amid Cost Pressures AMR Q1 2026 Earnings Metallurgical Coal Producer Posts Unexpected Loss as Earnings Miss Estimates by Wide Margin APG Q1 2026 Earnings EPS Beats Estimates Amid Unclear Revenue Picture XPON Q2 2025 Earnings Strong EPS Beat Highlights Cost Discipline M Q1 2026 Earnings EPS Beats Estimates by 673 as Stock Declines Nomura Holdings Q1 2026 Earnings Earnings Miss Weighs on Investor Sentiment MSCI Q1 2026 Earnings EPS Beats Estimates Shares Edge Higher Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline